Differential expression of Trypanosoma cruzi I associated with clinical forms of Chagas disease: Overexpression of oxidative stress proteins in acute patient isolate
Author
dc.contributor.author
Díaz, M. L.
Author
dc.contributor.author
Solari Illescas, Aldo
Author
dc.contributor.author
González, C. I.
Admission date
dc.date.accessioned
2019-03-11T13:02:21Z
Available date
dc.date.available
2019-03-11T13:02:21Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Journal of Proteomics, Volumen 74, Issue 9, 2018, Pages 1673-1682
Identifier
dc.identifier.issn
18743919
Identifier
dc.identifier.issn
18767737
Identifier
dc.identifier.other
10.1016/j.jprot.2011.05.001
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165331
Abstract
dc.description.abstract
Chagas disease has a variable clinical course with different manifestations and heterogenous geographical distribution. Some studies suggest that this clinical variability could be influenced by the genetic variability of T. cruzi. Here we present the differential protein expression among trypomastigotes and amastigotes of T. cruzi group I isolates from patients with acute and chronic form of Chagas disease from Santander, Colombia. A total of 29 proteins were identified by MALDI-TOF and LC-MS/MS; twenty in trypomastigote and nine in amastigote stage. The 29 proteins identified were grouped in 7 functional categories: 1) metabolism 31%, 2) assembly of cytoskeleton 13.7%, 3) protein destination 13.7%, 4) defenses antioxidants 20.6%, 5) protein synthesis and cellular cycle 13.7%, 6) catabolism 6.8%, and 7) adhesion 3.4%. Tryparedoxin peroxidase, lipoamide dehydrogenase, tyrosine amino transferase and HSP70 were overexpressed in the acute Chagas isolate. Tryparedoxin peroxidase overexpres
Differential expression of Trypanosoma cruzi I associated with clinical forms of Chagas disease: Overexpression of oxidative stress proteins in acute patient isolate